The amount of a reclassification adjustment made to prior period financial statement amounts.

No definition available.

Name:	us-gaap_PriorPeriodReclassificationAdjustment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Basis of Presentation (Details) - USD ($) $ in Thousands	12 Months Ended
Basis of Presentation (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Basis of Presentation [Line Items]
Prior period reclassification adjustment		$ (5,785)	$ (2,598)
Xenon Pharmaceuticals USA Inc. [Member]
Basis of Presentation [Line Items]
Date of incorporation	Dec. 02, 2016